StreetInsider.com News Articles

Form 8-K Guardian Pharmacy Servic For: May 21

Thu, 28 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260528/26567381.html

Form 8-K Guardian Pharmacy Servic For: May 21

Thu, 28 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260528/26567381.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: Patchett Mary Sue

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453853.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: Patchett Mary Sue

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453853.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: COSLER STEVEN D

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453863.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: COSLER STEVEN D

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453863.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: LEWIS RANDALL J

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453865.html

Form 4 Guardian Pharmacy Servic For: May 05 Filed by: LEWIS RANDALL J

Thu, 07 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260507/26453865.html

Form 8-K Guardian Pharmacy Servic For: May 05

Thu, 07 May 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260507/26453367.html

Form 8-K Guardian Pharmacy Servic For: May 05

Thu, 07 May 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260507/26453367.html

Guardian Pharmacy Services Inc. (GRDN) PT Raised to $43 at Oppenheimer

Thu, 07 May 2026 07:54:02 -0400

Oppenheimer analyst Michael Wiederhorn raised the price target on Guardian Pharmacy Services Inc. (NYSE: GRDN) to $43.00 (from $38.00) while maintaining a Outperform rating.

Guardian Pharmacy Services, Inc. (GRDN) Reports Q1 EPS of $0.29, provides guidance

Wed, 06 May 2026 17:02:20 -0400

Guardian Pharmacy Services, Inc. (NYSE: GRDN) reported Q1 EPS of $0.29. Revenue for the quarter came in at $336.6 million.

GUIDANCE:

Guardian Pharmacy Services, Inc. sees FY2026 revenue of $1.4-1.42 billion, versus the consensus of $1.414 billion.

For earnings history and earnings-related data on Guardian Pharmacy Services, Inc. (GRDN) click here.

Guardian Pharmacy Services, Inc. (GRDN) Reports Q1 EPS of $0.29, provides guidance

Wed, 06 May 2026 17:02:20 -0400

Guardian Pharmacy Services, Inc. (NYSE: GRDN) reported Q1 EPS of $0.29. Revenue for the quarter came in at $336.6 million.

GUIDANCE:

Guardian Pharmacy Services, Inc. sees FY2026 revenue of $1.4-1.42 billion, versus the consensus of $1.414 billion.

For earnings history and earnings-related data on Guardian Pharmacy Services, Inc. (GRDN) click here.

Form S-8 Guardian Pharmacy Servic

Wed, 06 May 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260506/26445023.html

Form S-8 Guardian Pharmacy Servic

Wed, 06 May 2026 16:47:00 -0400

si-local-file:///var/storage/secattach/20260506/26445023.html

Form S-3ASR Guardian Pharmacy Servic

Wed, 06 May 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260506/26444973.html

Form S-3ASR Guardian Pharmacy Servic

Wed, 06 May 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260506/26444973.html

Form 10-Q Guardian Pharmacy Servic For: Mar 31

Wed, 06 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260506/26444196.html

Form 10-Q Guardian Pharmacy Servic For: Mar 31

Wed, 06 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260506/26444196.html

Form 8-K Guardian Pharmacy Servic For: May 06

Wed, 06 May 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260506/26443962.html

Form 8-K Guardian Pharmacy Servic For: May 06

Wed, 06 May 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260506/26443962.html

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Wed, 06 May 2026 16:05:00 -0400

ATLANTA--(BUSINESS WIRE)-- Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance.

First Quarter Financial Results

Revenue of $336.6 million, up 2% year-over-year.
Residents served ended the quarter at approximately 207,000, up 10% year-over-year.
Net Income of $13.5 million, compared to $9.3 million in the prior-year period.
Adjusted EBITDA of $29.8 million, compared to $23.4 million in the prior-year period.
Diluted EPS of $0.21 for the quarter, with Adjusted EPS of $0.29.1
Cash and cash

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Wed, 06 May 2026 16:05:00 -0400

First Quarter Financial Results

Revenue of $336.6 million, up 2% year-over-year.
Residents served ended the quarter at approximately 207,000, up 10% year-over-year.
Net Income of $13.5 million, compared to $9.3 million in the prior-year period.
Adjusted EBITDA of $29.8 million, compared to $23.4 million in the prior-year period.
Diluted EPS of $0.21 for the quarter, with Adjusted EPS of $0.29.1
Cash and cash

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Wed, 06 May 2026 16:05:00 -0400

First Quarter Financial Results

Revenue of $336.6 million, up 2% year-over-year.
Residents served ended the quarter at approximately 207,000, up 10% year-over-year.
Net Income of $13.5 million, compared to $9.3 million in the prior-year period.
Adjusted EBITDA of $29.8 million, compared to $23.4 million in the prior-year period.
Diluted EPS of $0.21 for the quarter, with Adjusted EPS of $0.29.1
Cash and cash

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Wed, 06 May 2026 16:05:00 -0400

First Quarter Financial Results

Revenue of $336.6 million, up 2% year-over-year.
Residents served ended the quarter at approximately 207,000, up 10% year-over-year.
Net Income of $13.5 million, compared to $9.3 million in the prior-year period.
Adjusted EBITDA of $29.8 million, compared to $23.4 million in the prior-year period.
Diluted EPS of $0.21 for the quarter, with Adjusted EPS of $0.29.1
Cash and cash